central retinal vein


Also found in: Acronyms, Wikipedia.

cen·tral retinal vein

[TA]
the vein, formed by union of the retinal veins; accompanies the artery of the same name in the optic nerve.
Synonym(s): vena centralis retinae [TA]

Central retinal vein

Central blood vessel and its branches that drains the retina.
References in periodicals archive ?
Abstract: Central retinal vein occlusion has not been reported previously in patients with sickle cell anemia.
A snapshot of the global therapeutic scenario for Central Retinal Vein Occlusion.
EYLEA has been approved in almost 80 countries for the treatment of patients with wet AMD and around 60 countries for the treatment of visual impairment due to macular edema secondary to central retinal vein occlusion.
The efficacy of OZURDEX was assessed in two 6-month, prospective, double-masked, parallel-group studies in which 1267 patients with macular oedema due to either branch or central retinal vein occlusion (BRVO or CRVO) were randomised to receive either OZURDEX or a sham (placebo) procedure.
Then, most people are left with one central retinal vein.
1 ]In CRVO, the blockage occurs in the central retinal vein, the main blood vessel that carries de-oxygenated blood out of the back of the eye.
It includes a 10-year epidemiological forecast for the diagnosed prevalent cases of DME in the diagnosed diabetic retinopathy population and the total prevalent cases of ME following branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CRVO) segmented by sex and age (20-39 years, 40-59 years, 60-79 years, and =80 years) in these markets.
EYLEA has already been approved in Japan for the treatment of patients with neovascular age-related macular degeneration (wet AMD), and macular edema secondary to central retinal vein occlusion (CRVO).
Aflibercept solution for injection into the eye has already been approved under the brand name EYLEAA for the treatment of patients with neovascular age-related macular degeneration (wet AMD) and the treatment of visual impairment due to macular edema secondary to central retinal vein occlusion (CRVO).
Obstruction of the retinal vein at the optic nerve is referred to as central retinal vein occlusion (CRVO), and obstruction at a branch of the retinal vein is referred to as branch retinal vein occlusion (BRVO).
NASDAQ:REGN) today announced that the first patient has been enrolled in the Phase 3 program of VEGF Trap-Eye for the treatment of central retinal vein occlusion (CRVO), a leading cause of blindness in adults.
EYLEA has already been approved in Japan for the treatment of patients with neovascular (wet) age-related macular degeneration (AMD), and macular edema secondary to central retinal vein occlusion (CRVO).

Full browser ?